Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

United Therapeutics (UTHR) Debt Ratio (2017 - 2025)

United Therapeutics' Debt Ratio history spans 14 years, with the latest figure at 0.03 for Q1 2025.

  • On a quarterly basis, Debt Ratio fell 72.04% to 0.03 in Q1 2025 year-over-year; TTM through Mar 2025 was 0.03, a 72.04% decrease, with the full-year FY2024 number at 0.04, down 58.29% from a year prior.
  • Debt Ratio hit 0.03 in Q1 2025 for United Therapeutics, down from 0.04 in the prior quarter.
  • Over the last five years, Debt Ratio for UTHR hit a ceiling of 0.17 in Q1 2021 and a floor of 0.03 in Q1 2025.
  • Historically, Debt Ratio has averaged 0.12 across 5 years, with a median of 0.13 in 2023.
  • Biggest five-year swings in Debt Ratio: fell 10.72% in 2021 and later crashed 72.04% in 2025.
  • Tracing UTHR's Debt Ratio over 5 years: stood at 0.15 in 2021, then dropped by 14.48% to 0.13 in 2022, then dropped by 26.2% to 0.1 in 2023, then tumbled by 58.29% to 0.04 in 2024, then tumbled by 36.6% to 0.03 in 2025.
  • Business Quant data shows Debt Ratio for UTHR at 0.03 in Q1 2025, 0.04 in Q4 2024, and 0.06 in Q3 2024.